Linifanib (GMP), CAS 796967-16-3

Product Description: Linifanib (ABT-869) (GMP) is Linifanib (HY-50751) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Linifanib is a potent and orally active multi-target inhibitor of VEGFR and PDGFR family with IC50s of 4, 3, 66, and 4 nM for KDR, FLT1, PDGFRβ, and FLT3, respectively. Linifanib (GMP) promotes the generation and reprogramming of iPSCs from somatic cells[1].

Applications: Cancer-Kinase/protease

Formula: C21H18FN5O

References: [1]Guan J, et al. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022 May;605(7909):325-331.

CAS Number: 796967-16-3

Molecular Weight: 375.40

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PDGFR;VEGFR

• Artikelnummer: MEXHY-50751G-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-50751G-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK